Correction to “New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida”

Documenti analoghi

• Trends in management of patients with new‐onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis
  di: Aurelie Hanin, et al.
  Pubblicazione: (2024)
• New onset refractory status epilepticus: Long‐term outcomes beyond seizures
  di: Poul H. Espino, et al.
  Pubblicazione: (2025)
• Second‐line immunotherapy in new onset refractory status epilepticus
  di: Aurélie Hanin, et al.
  Pubblicazione: (2024)
• Clinical outcomes among initial survivors of cryptogenic new‐onset refractory status epilepsy ( NORSE )
  di: Daniel J. Costello, et al.
  Pubblicazione: (2024)
• Features affecting treatment decisions and outcome in refractory status epilepticus
  di: Charlotte Damien, et al.
  Pubblicazione: (2025)